Abstract
Objective:
This study aimed to compare the efficacy of levetiracetam versus phenytoin in early post-traumatic seizure prevention and ascertain the incidence of clinical seizures in traumatic brain injury (TBI).
Materials and Methods:
Adult patients with moderate to severe TBI in the neuroimaging consistent with brain injury were included in the study. Patients were categorized into two groups, the phenytoin or levetiracetam groups, based on the administration of antiepileptic drugs for seizure prophylaxis.
Results:
In this study, 100 patients with TBI met the inclusion criteria between January 2012 and June 2017, wherein 60 received seizure prophylaxis with phenytoin, and 40 with levetiracetam. The incidence of early post-traumatic seizure was 8%, without significant differences between groups (p>0.05). The incidence of clinical seizures after TBI was 10%.
Conclusion:
This report showed that levetiracetam and phenytoin had similar efficacy in posttraumatic seizure prophylaxis. This retrospective study design improved the reliability of comparison between phenytoin and levetiracetam for seizures in the two groups with similar features in terms of age, sex, injury mechanism, neuroimaging findings, and Glasgow coma, Marshall, and acute physiology and chronic health evaluation-II scores.
Keywords: Levetiracetam, phenytoin, seizure, trauma
References
- Kirmani BF, Mungall D, Ling G. Role of intravenous levetiracetam in seizure prophylaxis of severe traumatic brain injury patients. Front Neurol 2013;4:170.
- Yang Y, Zheng F, Xu X, Wang X. Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis. CNS Drugs 2016;30:677-88.
- Inaba K, Menaker J, Branco BC, Gooch J, Okoye OT, Herrold J, et al. A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis. J Trauma Acute Care Surg 2013;74:766-71.
- Xu JC, Shen J, Shao WZ, Tang LJ, Sun YZ, Zhai XF, et al. The safety and efficacy of levetiracetam versus phenytoin for seizure prophylaxis after traumatic brain injury: A systematic review and meta-analysis. Brain Inj 2016;30:1054-61.
- Jones KE, Puccio AM, Harshman KJ, Falcione B, Benedict N, Jankowitz BT, et al. Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury. Neurosurg Focus 2008;25:E3.
- Javed G, Waqas M, Qadeer M, Bari E, Murtaza G. Use of Levetiracetam in Prophylaxis of Early Post-Traumatic Seizures. Turk Neurosurg 2016;26:732-5.
- Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care 2010;12:165-72.
- Wilson CD, Burks JD, Rodgers RB, Evans RM, Bakare AA, Safavi-Abbasi S. Early and Late Posttraumatic Epilepsy in the Setting of Traumatic Brain Injury: A Meta-analysis and Review of Antiepileptic Management. World Neurosurg 2018;110:e901-6.
- Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990;323:497-502.
- Zangbar B, Khalil M, Gruessner A, Joseph B, Friese R, Kulvatunyou N, et al. Levetiracetam Prophylaxis for Post-traumatic Brain Injury Seizures is Ineffective: A Propensity Score Analysis. World J Surg 2016;40:2667-72.
- Bhullar IS, Johnson D, Paul JP, Kerwin AJ, Tepas JJ 3rd, Frykberg ER. More harm than good: antiseizure prophylaxis after traumatic brain injury does not decrease seizure rates but may inhibit functional recovery. J Trauma Acute Care Surg 2014;76:54-60.
- Kruer RM, Harris LH, Goodwin H, Kornbluth J, Thomas KP, Slater LA, et al. Changing trends in the use of seizure prophylaxis after traumatic brain injury: a shift from phenytoin to levetiracetam. J Crit Care 2013;28:883.e9-13.
Copyright and license
Copyright © 2022 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.
